Correlation Between Gilead Sciences and Edge Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Gilead Sciences and Edge Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gilead Sciences and Edge Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Gilead Sciences and Edge Therapeutics, you can compare the effects of market volatilities on Gilead Sciences and Edge Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gilead Sciences with a short position of Edge Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gilead Sciences and Edge Therapeutics.

Diversification Opportunities for Gilead Sciences and Edge Therapeutics

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Gilead and Edge is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Gilead Sciences and Edge Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Edge Therapeutics and Gilead Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gilead Sciences are associated (or correlated) with Edge Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Edge Therapeutics has no effect on the direction of Gilead Sciences i.e., Gilead Sciences and Edge Therapeutics go up and down completely randomly.

Pair Corralation between Gilead Sciences and Edge Therapeutics

If you would invest (100.00) in Edge Therapeutics on January 26, 2024 and sell it today you would earn a total of  100.00  from holding Edge Therapeutics or generate -100.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Gilead Sciences  vs.  Edge Therapeutics

 Performance 
       Timeline  
Gilead Sciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Gilead Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's essential indicators remain rather sound which may send shares a bit higher in May 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Edge Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Edge Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Edge Therapeutics is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.

Gilead Sciences and Edge Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Gilead Sciences and Edge Therapeutics

The main advantage of trading using opposite Gilead Sciences and Edge Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gilead Sciences position performs unexpectedly, Edge Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edge Therapeutics will offset losses from the drop in Edge Therapeutics' long position.
The idea behind Gilead Sciences and Edge Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments